Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

MYOGLOBIN - ANVISA Registration 81472060042

Access comprehensive regulatory information for MYOGLOBIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81472060042 and manufactured by HANGZHOU AICHEK MEDICAL TECHNOLOGY CO., LTD.. The registration is held by ADVAGEN BIOTECH LTDA with validity until May 26, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, QINGDAO HIGHTOP BIOTECH CO.,LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
81472060042
2 Related Devices
Registration Details
ANVISA Registration Number: 81472060042
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

Teste Rรกpido Mioglobina
Risk Class III

Registration Details

81472060042

25351453983202418

22565307000172

Company Information

China
PT: CHINA, REPรšBLICA POPULAR

Dates and Status

May 26, 2025

26/05/2035

09/18/2025 19:00:01

Teste Rรกpido Mioglobina
Risk Class III

Registration Details

81472060042

25351453983202418

22565307000172

Company Information

Dates and Status

May 26, 2025

26/05/2035

09/18/2025 19:00:01